Cargando…
Futureproofing [(18)F]Fludeoxyglucose manufacture at an Academic Medical Center
BACKGROUND: We recently upgraded our [(18)F]fludeoxyglucose (FDG) production capabilities with the goal of futureproofing our FDG clinical supply, expanding the number of batches of FDG we can manufacture each day, and improving patient throughput in our nuclear medicine clinic. In this paper we rep...
Autores principales: | Sowa, Alexandra R, Jackson, Isaac M, Desmond, Timothy J, Alicea, Jeremiah, Mufarreh, Anthony J, Pham, Jonathan M, Stauff, Jenelle, Winton, Wade P, Fawaz, Maria V, Henderson, Bradford D, Hockley, Brian G, Rogers, Virginia E, Koeppe, Robert A, Scott, Peter J H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173674/ https://www.ncbi.nlm.nih.gov/pubmed/30363401 http://dx.doi.org/10.1186/s41181-018-0048-x |
Ejemplares similares
-
Futureproof
por: Dial, Minter
Publicado: (2017) -
Towards a Futureproof Zoo
por: Keulartz, Jozef
Publicado: (2023) -
Futureproof: how to build resilience in an uncertain world
por: Coaffee, Jon
Publicado: (2019) -
How can we futureproof vet education?
por: Andrews, Bryanna
Publicado: (2020) -
Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET
por: Brooks, Allen F., et al.
Publicado: (2022)